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Purpose: The aim of this investigation was to analyze whether the following platelet indices are useful
markers for functional dependence and 1-year all-cause hospitalization and mortality in the elderly
population: platelet count (PLT), platelet distribution width (PDW), mean platelet volume (MPV), and
plateletelarge cell ratio (P-LCR).
Methods: The 119 participants in this study were 90 women and 29 men between the ages of 68 and 105
years who were selected from the Santa Teresa nursing home (Oviedo, Spain). We studied morbidity,
sociodemographic characteristics, and functional status using the Barthel Index (BI) and Katz Index (KI)
for activities of daily living.
Results: In logistic regression models adjusted for age, sex, and anti-inﬂammatory drug use, low levels of
PDW were associated with death at 1 year. When we applied logistic regression models adjusted for
morbid conditions as well as age, sex, and anti-inﬂammatory drug use, the PDW remained statistically
signiﬁcant. No relation between PLT, MPV, or P-LCR and mortality was found. No statistical associations
between the platelet indices studied and functional dependence or hospitalization were observed.
Conclusion: Our data suggest that the PDW could be a predictor of 1-year mortality in the elderly pop-
ulation and may therefore serve as a useful tool for identifying individuals with a high risk of mortality
who may beneﬁt from preventative care or early-stage strategies.
Copyright  2012, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
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Aging is associated with an increased risk of functional depen-
dence, hospitalization and mortality. The age-related physiological
decline is intimately associated with poor quality of life, the need
for long-term care and higher healthcare costs.1 Therefore, many
recent studies have investigated the usefulness of various param-
eters as biomarkers for adverse clinical outcomes in the elderly.2e5
One important focus of this ﬁeld is to determine whether typical
parameters of automated blood cell counters demonstrate anology and Cellular Biology,
of Oviedo, Julián Clavería s/n,
. de Gonzalo-Calvo), acoto@
linical Gerontology & Geriatrics. Passociationwith adverse outcomes in the elderly. For example, total
leucocytes and some subpopulations of leucocytes have been
associated with frailty.6,7 In addition, red blood cell distribution
width seems to be a good indicator of mortality in older adults.8,9
Platelet indices have received an increasing amount of attention
as potential markers for disease. Several epidemiological studies
have reported platelet indices, in particular the mean platelet
volume (MPV), as markers for cardiovascular disease. Elevated MPV
has been proposed as a risk factor for ischemic heart disease.10 High
levels of MPV seem to be associated with acute myocardial infarc-
tion and mortality following myocardial infarction, suggesting that
MPV is a potentially useful prognostic biomarker in patients with
cardiovascular disease.11 However, the current knowledge of the
usefulness of platelet indices as markers for adverse clinical
outcomes, such as functional dependence or hospitalization, in the
elderly population is limited. The lack of data addressing this issueublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
D. de Gonzalo-Calvo et al. / Journal of Clinical Gerontology & Geriatrics 4 (2013) 12e16 13is somewhat surprising when one considers the relevant health,
social, and economic implications of adverse clinical outcomes of
elderly subjects and the need to identify risk factors at a stage of
age-related decline that would be amenable to preventive inter-
ventions. In addition, the availability of powerful biological markers
for functional dependence, hospitalization, and mortality would
allow for an assessment of the efﬁcacy of possible interventions.
To address this issue, we analyzed the association of the
following platelet indices with functional dependence and 1-year
all-cause hospitalization and mortality in elderly subjects:
platelet count (PLT), platelet distribution width (PDW), MPV, and
plateletelarge cell ratio (P-LCR). The ultimate goal of this study was
to identify potentially useful biological markers for clinical practice.
2. Methods
2.1. Participants
Participants were selected from the Santa Teresa nursing home
(Oviedo, Spain), and all those over 65 years old were considered for
the current investigation. Exclusion criteria were recent or current
infection, malignant disease, malnutrition, and pharmacological
interference (immunosuppressive and antineoplasic drugs and
testosterone). Malnutritionwas deﬁned as a recent (at least 1month
prior to enrollment in the study) measurement of serum albumin
level of less than 3 g/dL. Participants were not selected based on
morbidity characteristics. The participants were recruited from
November 2008 to February 2009. During 1 year of follow-up, the
number of hospitalizations and the patients’ vital status were re-
ported by internal nursing home clinicians. Follow-up of the cohort
was 98% complete for hospitalization reports (1-year hospitalization
data for two individuals was lost) and 99% complete for mortality
reports (1-yearmortality data for one individualwas lost). Bloodwas
drawnfromallof theparticipants. Initial evaluationswere carriedout
by experienced geriatricians and included an exhaustive review of
the subject’s medical and pharmacological history, a physical
examination, andaphysical activity questionnaire. Thedisease status
of apatientwasbasedonanexplicit diagnosis in thepatient’smedical
history. Diseases that were considered in the current analysis were
cognitive impairment, dementia, osteoporosis, hypertension,
chronic obstructive pulmonary disease, osteoarthritis, depression,
heart failure, ischemic heart disease, rheumatoid arthritis, hyper-
thyroidism, cancer, dyslipidemia, and type 2 diabetes. The diagnosis
of cognitive impairment and dementiawas based on the Pfeiffer test
(SMPSQ) and the criteria of the Diagnostic and Statistical Manual of
Mental Disorders, fourth edition (DSM-IV), respectively.
The functional abilities of the subjects were assessed using the
Barthel Index (BI) and Katz Index (KI).12,13 BI is a ten-item scale with
an assessment of the following activities: feeding, grooming,
bathing, toilet use, dressing, walking, transfers, climbing stairs,
fecal incontinence, and urinary incontinence. The highest score is
100 (independence), and the lowest score is 0 (total dependence).
KI ranks the adequacy of performance of the following six func-
tions: bathing, dressing, using the toilet, transferring, continence,
and feeding. The subjects were scored using ‘yes’ or ‘no’ for inde-
pendence in each of the six functions. A score of 6 indicates severe
functional impairment, and a score of 0 indicates functional inde-
pendence. BI and KI were assessed by nursing aides who live with
the patient and can therefore objectively and effortlessly evaluate
the performance of the individual. The functional status of each
subject was assessed during theweek prior to inclusion in the study
to eliminate subjective bias caused by interrogation regarding
a particular subject.
Each participant or the participant’s guardian received infor-
mation about the purposes and objectives of the study and signedan informed consent form. The study was approved by the Hospital
Central de Asturias (Oviedo, Spain) Ethics Committee.
2.2. Blood collection
Blood samples were obtained by venipuncture following an
overnight fast and 15-minute rest in the morning. All venous blood
samples were obtained in themorning before 10:00 AM to preclude
circadian variation. The blood samples were drawn into BD Vacu-
tainer tubes (BD, Franklin Lakes, NJ, USA).
2.3. Biochemical analysis
Serum albumin level was analyzed by a well-standardized
hematology laboratory at the Monte Naranco Hospital (Oviedo,
Spain). The following platelet indices were measured using an
automated hematology analyzer SYSMEX SF-3000 (GMI Inc.,
Ramsey, MI, USA) in the same laboratory: platelet count (PLT),
platelet distribution width (PDW), mean platelet volume (MPV),
and plateletelarge cell ratio (P-LCR).
2.4. Statistical analysis
Descriptive statistics were used to characterize the study pop-
ulation and to describe the studied parameters at baseline. The data
were expressed as frequencies (percentages) for categorical vari-
ables and the mean  standard deviation (SD) for continuous
variables. The normality of the data was analyzed using the
KolmogoroveSmirnov test.
The linear regression analysis for each measurement of physical
performance (BI and KI) was ﬁtted against each marker after
adjusting for age, sex, and anti-inﬂammatory drug use (model 1) to
account for potential confounding variables. To establish whether
the association of marker levels and BI and KI were inﬂuenced by
morbid conditions, sequential linear regressions were also adjusted
for age, sex, anti-inﬂammatory drug use, and total number of
diseases per subject, including diagnoses of cognitive impairment,
dementia, osteoporosis, hypertension, chronic obstructive pulmo-
nary disease, osteoarthritis, depression, heart failure, ischemic
heart disease, rheumatoid arthritis, hyperthyroidism, cancer, dys-
lipidemia, and type 2 diabetes (model 2).
Sequential logistic regressions for at least one hospitalization
compared with nonhospitalized patients during 1 year and for
death versus survival at 1 year were performed for each of the
platelet markers measured at baseline, with adjustments made for
age, sex, and anti-inﬂammatory drug use (model 1). To establish
whether the observed association of biomarker levels with 1-year
hospitalization or 1-year mortality could be altered by morbid
conditions, sequential logistic regressions were also adjusted for
age, sex, anti-inﬂammatory drug use, and the total number of
diseases per participant (model 2). The results were presented as an
odds ratio (OR) and 95% conﬁdence interval (CI). The area under the
receiver operating characteristic (ROC) curve (AUC) of PDWmodels
was analyzed. The Youden Index was estimated.
The statistical software package SPSS 15.0 for Windows (SPSS
Inc., Chicago, IL, USA) was used for all statistical analyses. Differ-
ences were considered statistically signiﬁcant when p < 0.05.
3. Results
Demographic and clinical characteristics for the sample pop-
ulation are shown in Table 1. The mean age of the sample pop-
ulation was 86  7 years. The prevalence of women was 75.6%. The
sample population displayed awide range of functional statuses (BI
score ¼ 0e100; KI score ¼ 0e6). The study included 94
Table 1
Characteristics of the sample population.
Characteristics n ¼ 119
Age (y) 86  7
Female 90 (75.6)
Male 29 (24.4)
Barthel Index 67  34
Katz Index 2  2
Total number of medical diagnoses per patient 2  1
Cognitive impairment 20 (16.8)
Dementia 12 (10.1)
Osteoporosis 27 (22.7)
Hypertension 45 (37.8)
Chronic obstructive pulmonary disease 15 (12.6)
Osteoarthritis 28 (23.5)
Depression 21 (17.6)
Heart failure 6 (5.0)
Ischemic heart disease 8 (6.7)
Rheumatoid arthritis 2 (1.7)
Hyperthyroidism 2 (1.7)
Dyslipidemia 20 (16.8)
Type 2 diabetes 18 (15.1)
Total number of medications per patient 6  3
Taking steroidal anti-inﬂammatory drugs 3 (2.5)
Taking nonsteroidal anti-inﬂammatory drugs 44 (36.9)
PLT (103/mL) 218.10  73.28
PDW (fL) 13.85  2.60
MPV (fL) 11.32  1.14
P-LCR (%) 35.86  9.13
Data are expressed as the mean  SD for continuous variables and as frequencies
(percentages) for categorical variables.
MPV¼mean platelet volume; PDW¼ platelet distribution width; P-LCR¼ platelete
large cell ratio; PLT ¼ platelet count.
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hospitalization during a 1-year period (19% of subjects). The study
included 99 survivors and 19 participants who died during the 1-
year study (16% of subjects).
Table 2 displays the linear regression models that were used to
examine the relationship between the platelet indices and func-
tional dependence using BI and KI as outcome measurements. In
linear regressions that were adjusted by age, sex, and anti-
inﬂammatory drug use, no association between platelet indices
and BI or KI were reported. Because platelet indices have been
correlated with several chronic diseases, an additional analysis was
conducted to determine whether the incidence of diseases altered
the relationship between platelet indices and BI or KI scores. When
we applied linear regressions that were adjusted by age, sex, anti-
inﬂammatory drug use, and morbid conditions, no statistically
signiﬁcant association was found.
Logistic regressionmodelswereused toexamine the relationship
between the platelet indices analyzed and either hospitalization orTable 2
Association between platelet indices and functional dependence.
Variable Model 1
B (95% CI) b p
Barthel Index
PLT (103/mL) 0.059 (0.024, 0.141) 0.125 0
PDW (fL) 1.205 (1.097, 3.507) 0.091 0
MPV (fL) 2.240 (3.048, 7.528) 0.074 0
P-LCR (%) 0.255 (0.406, 0.916) 0.067 0
Katz Index
PLT (103/mL) 0.003 (0.008, 0.002) 0.099 0
PDW (fL) 0.078 (0.222, 0.066) 0.095 0
MPV (fL) 0.164 (0.494 0.166) 0.087 0
P-LCR (%) 0.020 (0.061, 0.021) 0.084 0
Model 1 is adjusted for age, sex, and anti-inﬂammatory drug use.
Model 2 is adjusted for age, sex, anti-inﬂammatory drug use, and morbid conditions.
b¼ standardized betas; B¼ betas; CI¼ conﬁdence intervals; MPV¼mean platelet volume
count.mortality at 1 year (Table 3). In regressions adjusted by age, sex, and
anti-inﬂammatory druguse, lowlevels of PDWwereassociatedwith
at least one hospitalization during the study period with nearly
signiﬁcant differences, even after adjusting by morbid conditions.
An association with 1-year mortality was observed for low levels of
PDW in a model adjusted for age, sex, and anti-inﬂammatory drug
use. Adjustment for morbid conditions retained statistical signiﬁ-
cance. A nearly signiﬁcant relationship betweenMPV and P-LCR and
1-year mortality was found for both mortality models.
Because of the association of PDW regressionmodels and 1-year
mortality we analyzed the AUC for both models. For model 1, AUC
(95% CI) was 0.706 (0.596e0.815), sensitivity was 0.895, speciﬁcity
was 0.46, and the cut-off point was 0.113. For model 2, AUC (95% CI)
was 0.734 (0.619e0.849), sensitivity was 0.842, speciﬁcity was 0.61,
and the cut-off point was 0.152.4. Discussion
In this study, we tested the hypothesis that platelet indices are
associated with functional dependence and 1-year all-cause
hospitalization and mortality in the elderly. The ultimate goal of
this study was to identify potentially useful biological markers for
clinical practice. Our results showed that institutionalized older
subjects with lower PDW levels present a higher risk of mortality
within 1 year. These results were statistically signiﬁcant after
adjusting for age, sex, anti-inﬂammatory use, and morbid condi-
tions. It is important to point out that the AUC for both 1-year
mortality models were elevated, indicating a good accuracy of the
models obtained. Our ﬁndings are notable given that PDW is widely
available to clinicians as part of the complete blood count and
therefore incurs no additional costs.14 Subjects with low PDW could
be identiﬁed during routine hematological analysis and could
possibly beneﬁt from preventive treatment.
We obtained conﬂicting results from our analysis of the rela-
tionship between platelet indices and health status. MPV, PDW, and
P-LCR were reported to be signiﬁcantly higher in patients with
diabetes compared to the control subjects. Furthermore, among
patients with diabetes, the PDW was higher in those with micro-
vascular complications.15 MPV, PDW, and P-LCR were elevated in
patients with acute myocardial infarction and unstable angina
compared with stable coronary artery disease subjects and
matched healthy controls with no history of heart disease.16
However, previous studies proposed that MPV, PDW, and P-LCR
were signiﬁcantly lower in aortic aneurysm subjects than in age-
matched healthy controls.17 De Luca and colleagues proposed that
PDW levels are not related to extent of coronary artery disease and
concluded that the PDW cannot be considered as a risk factor forModel 2
B (95% CI) b p
.161 0.058 (0.025, 0.141) 0.124 0.168
.302 1.183 (1.143, 3.509) 0.089 0.316
.403 2.178 (2.874, 7.691) 0.072 0.422
.446 0.247 (0.423, 0.916) 0.065 0.467
.270 0.003 (0.008, 0.002) 0.100 0.267
.285 0.080 (0.225, 0.066) 0.097 0.279
.328 0.169 (0.504, 0.165) 0.090 0.319
.343 0.021 (0.062, 0.021) 0.087 0.333
; PDW¼ platelet distribution width; P-LCR¼ plateletelarge cell ratio; PLT¼ platelet
Table 3
Associations between platelet indices and subsequent 1-year all-cause hospitalization or mortality.
Variable Hospitalization Mortality
Model 1 Model 2 Model 1 Model 2
OR (95 % CI) p OR (95 % CI) p OR (95 % CI) p OR (95 % CI) p
PLT (*103/mL) 0.998 (0.992, 1.005) 0.617 0.998 (0.991, 1.004) 0.503 1.000 (0.993, 1.007) 0.993 1.000 (0.993, 1.007) 0.987
PDW (fL) 0.811 (0.636, 1.034) 0.092 0.790 (0.611, 1.020) 0.071 0.761 (0.583, 0.993) 0.044* 0.761 (0.583, 0.993) 0.044*
MPV (fL) 0.754 (0.470, 1.209) 0.241 0.700 (0.422, 1.162) 0.168 0.638 (0.381, 1.068) 0.087 0.611 (0.360, 1.035) 0.067
P-LCR (%) 0.966 (0.910, 1.024) 0.246 0.957 (0.899, 1.019) 0.172 0.947 (0.889, 1.009) 0.095 0.942 (0.883, 1.006) 0.074
Model 1 is adjusted for age, sex, and anti-inﬂammatory drug use.
Model 2 is adjusted for age, sex, anti-inﬂammatory drug use, and morbid conditions.
*Statistically signiﬁcant.
CI ¼ conﬁdence interval; MPV ¼ mean platelet volume; OR ¼ odds ratio; PDW ¼ platelet distribution width; P-LCR ¼ plateletelarge cell ratio; PLT ¼ platelet count.
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that platelet indices could be used as potential markers of platelet
activation,19,20 others showed that platelet indices could not be
used as an indicator of this phenomenon.21 Therefore, a discrep-
ancy between previous studies and our data is conceivable.
We cannot conclude whether the relationship between 1-year
all-cause death and PDW in institutionalized elderly population is
causal. Interestingly, high levels of interleukin-6 and white blood
cells were negatively associated with PDW, indicating a possible
relationship between inﬂammation and PDW.20,22 PDW reﬂects the
variability in platelet size. Previous data suggest a possible inﬂu-
ence of chronic inﬂammation on PDW values; the data supporting
this possibility include platelet size heterogeneity because of the
production of factors in the bone marrow and not of their matu-
ration during circulation,23 the regulation of thrombopoiesis by
inﬂammatory mediators,24 and the association of mortality with
chronic inﬂammation in the elderly population.25,26 Indeed,
subclinical chronic inﬂammation, deﬁned by a two- to fourfold
increase in the levels of circulating pro-inﬂammatory mediators, is
an underlying biological mechanism responsible for health decline
in the elderly.27e29 This phenomenon is corroborated by recent
data from our laboratory: we have shown a close association
between higher levels of inﬂammatory parameters and 1-year
mortality in the same study population as presented in this
study.8 Accordingly, the PDW might be considered as a surrogate
marker of chronic inﬂammation rather than a direct causal factor of
functional decline.
No correlation between PLT, MPV, or P-LCR and mortality was
identiﬁed. Furthermore, no associations were found between the
platelet indices analyzed and functional dependence or 1-year
hospitalization. Prior to this study, there was a lack of data inves-
tigating an association between platelet indices and adverse clinical
outcomes in the elderly population. Our ﬁndings provide additional
information on platelet indices in relation to functional depen-
dence, hospitalization, and mortality in elderly patients.
There are several noteworthy limitations to this study. First,
a larger population size would have been desirable; the sample size
is too small to perform adjusted stratiﬁed analyses in different
clinical subgroups. Further, the sample size of this study was not
large enough to test for cause-speciﬁc hospitalization and
mortality. Regarding functional dependence, because of the cross-
sectional characteristics of this study, we could not determine
a causal explanation for the observed association between platelet
indices and physical function. Finally, we cannot exclude the effect
of diseases that were not recorded on subsequent outcomes,
including subclinical inﬂammatory diseases. Based on these limi-
tations, a cautious interpretation of these results is warranted.
We conclude that low PDW values could be a predictor of
subsequent 1-yearmortality in institutionalized elderly populations.
ThePDWmaythereforeprovideauseful tool in translational research
for identifying elderly peoplewho have a high risk of death andmaybeneﬁt frompreventive or early-stage strategies. Given these results,
a more detailed investigation of this topic will be of great interest.
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